Scientific Program - Friday, November 20, 2015

Print

Session type:
Person:
Clear filters

Morning

07:00 a.m. - 08:00 a.m.
Industry Sponsored Breakfast
Location: Mouton


08:00 a.m. - 09:00 a.m.
Surgery for Female Sexual Concerns
Location: Latour Ballroom 2
Moderators: Seth Cohen, MD, MPH & Michael Krychman, MD

08:00 a.m. - 08:20 a.m.
Reconstruction after FGC
Crista E. Johnson-Agbakwu, MD, MSc

08:20 a.m. - 08:40 a.m.
Management of Sexual Pain
Irwin Goldstein, MD

08:40 a.m. - 09:00 a.m.
Cosmetic Genital Surgery
Christine Hamori, MD


09:00 a.m. - 09:30 a.m.
History of Penile Surgery for ED
Location: Latour Ballroom 2
Moderators: William O. Brant, MD & Lawrence S. Hakim, MD, FACS

09:00 a.m. - 09:15 a.m.
History of Vascular Surgery for ED
Ronald Virag, MD

09:15 a.m. - 09:30 a.m.
History of Prosthetic Surgery: F. Brantley Scott ED
David F. Mobley, MD


09:30 a.m. - 09:45 a.m.
Coffee Break
Location: Latour Ballroom 3, 5, 6 & 7


09:45 a.m. - 10:30 a.m.
Using Social Media to Promote your Practice
Location: Latour Ballroom 2
Moderator: Andrew C. Kramer, MD

09:45 a.m. - 10:00 a.m.
Using Social Media to Promote your Practice
Brian Steixner, MD

10:00 a.m. - 10:30 a.m.
Using Social Media to Promote your Practice
Farris K. Timimi, MD


10:30 a.m. - 11:30 a.m.
Medicolegal Issues in Sexual Medicine
Location: Latour Ballroom 2
Moderator: John Mulhall, MD

10:30 a.m. - 10:40 a.m.
How to Minimize Complications and Litigation in Penile Surgery
David Ralph, MS, FRCS

10:40 a.m. - 10:55 a.m.
The Anatomy of a Lawsuit – Avoiding Pitfalls
Mark E. Nichols, Esq.

10:55 a.m. - 11:10 a.m.
Mindset for Suit Survival
Luis Quintero, MD, FACEP

11:10 a.m. - 11:30 a.m.
Q&A


11:30 a.m. - 11:55 p.m.
AUA Update
Location: Latour Ballroom 2

11:30 a.m. - 11:45 p.m.
AUA Secretary Address
Manoj Monga, MD, FACS

11:45 a.m. - 11:55 a.m.
AUA Update - Research
Carolyn Best, PhD


11:55 a.m. - 12:00 p.m.
JSM Update
Location: Latour Ballroom 2
Moderator: John Mulhall, MD


Afternoon

12:00 p.m. - 01:30 p.m.
Special SMSNA Lunch Symposium on Hypogonadism (Independent Satellite Symposium, CME-certified)
Location: Mouton


01:30 p.m. - 02:30 p.m.
ESSM Symposium on Peyronie’s Disease: What’s next?
Location: Latour Ballroom 2
Moderator: David Ralph, MS, FRCS

01:30 p.m. - 01:47 p.m.
Phenotypic Screening for Peyronie's Disease: A new hope for new therapeutics?
Selim Cellek, MD, PhD

01:47 p.m. - 02:04 p.m.
Patients bother in Peyronie's Disease
Yacov Reisman, MD, PhD

02:04 p.m. - 02:19 p.m.
The 2015 ICSM Guidelines for Peyronie’s Disease
David Ralph, MS, FRCS

02:20 p.m. - 02:30 p.m.
Minimally Invasive Treatment of PD with PRP and Hyaluronic Acid
Ronald Virag, MD


01:30 p.m. - 02:30 p.m.
Use of Androgens in Women
Location: Margaux 1
Moderators: Irwin Goldstein, MD & Michael Krychman, MD

01:30 p.m. - 01:50 p.m.
Actions of Testosterone in Women
Noel N. Kim, PhD

01:50 p.m. - 02:10 p.m.
Testosterone Therapy in Women: The Evidence
Sharon J. Parish, MD, IF, NCMP

02:10 p.m. - 02:30 p.m.
Testosterone in Women with History of Gyne/Breast Cancers
Mindy E. Goldman, MD


01:30 p.m. - 02:30 p.m.
Basic Science of Priapism: New Paradigms
Location: Margaux 2
Moderators: Arthur L. Burnett II, MD & Biljana Musicki, PhD

01:30 p.m. - 02:00 p.m.
Pathophysiology of Priapism
Kelvin Davies, BSc, MSc, PhD

02:00 p.m. - 02:30 p.m.
Clinical Applications of Basic Science in Priapism
Arthur L. Burnett II, MD


01:30 p.m. - 04:00 p.m.
APN-PA Hands-on Stations
Location: Lafleur 2
Moderator: Kenneth Mitchell, MPAS, PA-C

01:30 p.m. - 02:00 p.m.
Testopel
Peter Veneziano, PA

02:00 p.m. - 02:30 p.m.
Xiaflex
Joseph B. Narus, DNP, APRN, NP-BC

02:30 p.m. - 03:00 p.m.
Coding
Susanne Talebian, CHBC, RMM, CMOM, CPC-I, CPC, CUA, CCS-P, PCS

03:00 p.m. - 03:30 p.m.
Penile Injections
Kevin Flinn, RN

03:30 p.m. - 04:00 p.m.
Male Genital Exam
Jeffrey Albaugh, PhD, APRN, CUCNS


02:30 p.m. - 03:00 p.m.
Off Label Management of Testosterone Deficiency
Location: Latour Ballroom 2
Moderators: Andrew R. McCullough, MD & Charles Welliver, MD

02:30 p.m. - 02:45 p.m.
Anastrazole
Alexander W. Pastuszak, MD, PhD

02:45 p.m. - 03:00 p.m.
HCG
Landon W. Trost, MD


02:30 p.m. - 04:00 p.m.
Moderated Posters: Basic Science I
Location: Margaux 2
Moderators: Kelvin Davies, BSc, MSc, PhD & Johanna Hannan, PhD

02:30 p.m. - 02:37 p.m.
Neuronal and Sonic Hedgehog Regulation of Collagen Abundance and Development in the Penis (#014)
Carol A. Podlasek, PhD

02:37 p.m. - 02:44 p.m.
Sepiapterin Supplementation Fails to Ameliorate Diesel Exhaust Particle Exposure-Related Erectile and Coronary Artery Dysfunction in Young Lewis Rats (#015)
C.J. Wingard

02:44 p.m. - 02:51 p.m.
Development of a High-Throughput, Cell-Based Assay for Anti-Myofibroblast Activity in Peyronie’s Disease (#016)
M. Mateus

02:51 p.m. - 02:58 p.m.
Development of Gene Therapy for Erectile Dysfunction: Delivery to Corpus Cavernosa using Viral Vectors (#017)
R. Terlecki

02:58 p.m. - 03:05 p.m.
Mirabegron Elicits Smooth Muscle Relaxation of Human and Rat Corpus Cavernosum Tissues via Non Nitric Oxide-cGMP Pathways (#018)
F.A. Yafi

03:05 p.m. - 03:12 p.m.
Vascular Endothelial Growth Factor and Antioxidants Improve Erectile Function in Diabetic Rats (#019)
L. DeYoung

03:12 p.m. - 03:19 p.m.
Regulation of Sphingosine-1-Phosphate (S1P) Signaling Pathway in Rats and Humans and Alterations in Response to Pathologically-Induced Erectile Dysfunction (#020)
Michael E. DiSanto, PhD

03:19 p.m. - 03:26 p.m.
SDF-1 Treatment Promotes Neurite Outgrowth from the Major Pelvic Ganglion by Upregulating Neurotrophins (#021)
Nikolai Sopko, MD, PhD

03:26 p.m. - 03:33 p.m.
Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in the Pathogenesis of Peyronie’s Disease (#022)
L. DeYoung

03:33 p.m. - 03:40 p.m.
Harnessing the Role of Microtubules in Neural Regeneration to Improve Erectile Function Outcomes Following Cavernous Nerve Injury in a Rat Model of Radical Prostatectomy (#023)
Kelvin Davies, BSc, MSc, PhD

03:40 p.m. - 03:47 p.m.
TNF-alpha Inhibits Neurite Outgrowth from the Major Pelvic Ganglion by Inducing Apoptosis of Nitrergic Neurons Ex Vivo (#024)
H. Matsui

03:47 p.m. - 03:54 p.m.
New Methodology for Investigating Ejaculation Dysfunction: Measuring Intraluminal Seminal Vesicle Pressure in Rats with Telemetric Device (#025)
S.W. Lee

03:54 p.m. - 04:00 p.m.
The Effect of Dietary Iron Intake on Intratesticular Metal Concentrations (#026)
J.S. Gabrielsen


03:00 p.m. - 04:00 p.m.
Moderated Posters: Androgens I
Location: Latour Ballroom 2
Moderators: Selim Cellek, MD, PhD & Abraham Morgentaler, MD

03:00 p.m. - 03:05 p.m.
Diagnostic Accuracy of a Single Serum Testosterone Measurement: The False Negative Rate (#027)
X. Ni

03:05 p.m. - 03:10 p.m.
Efficacy and Pharmacokinetics of Oral Testosterone (LPCN 1021) in Hypogonadal Men (#028)
Irwin Goldstein, MD

03:10 p.m. - 03:15 p.m.
Testosterone Solution 2% for Erectile, Orgasmic and Ejaculatory Dysfunction in Hypogonadal Men (#029)
D.A. Paduch

03:15 p.m. - 03:20 p.m.
Dose Titration and Safety of Oral Testosterone in Hypogonadal Men: Results from the SOAR Study (#030)
Mohit Khera, MD

03:20 p.m. - 03:25 p.m.
Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo-Controlled Study (#031)
Gerald B. Brock, MD

03:25 p.m. - 03:30 p.m.
The Construct Validity of the Patient-Reported Outcome Instruments Sexual Arousal, Interest, and Drive Scale (SAID) and the Hypogonadism Energy Diary (HED) (#032)
D. Heiselman

03:30 p.m. - 03:35 p.m.
An Assessment Of The Impact Of Testosterone Supplementation Therapy On Hemoglobin A1C (HbA1C) Levels In Diabetic And Non-Diabetic Men (#033)
John Mulhall, MD

03:35 p.m. - 03:40 p.m.
Diagnostic Accuracy of a Single Serum Testosterone Measurement (#034)
X. Ni

03:40 p.m. - 03:45 p.m.
Improvement of Endothelial Function Following Initiation of Testosterone Replacement Therapy (#035)
D. Shoskes

03:45 p.m. - 03:50 p.m.
Assessment of Fasting and Varying Meal Fat Content on the Bioavailability of Oral Testosterone Undecanoate (LPCN 1021) in Hypogonadal Men (#036)
Mohit Khera, MD

04:45 p.m. - 04:50 p.m.
Twice Weekly Dosing of Injectable Testosterone Associated with Increased Erythrocytosis (#037)
S.J. Ohlander


04:00 p.m. - 05:00 p.m.
Industry Sponsored Reception
Location: Mouton


05:00 p.m. - 05:45 p.m.
ASMH Session
Location: Latour Ballroom 2
Moderators: Gregory A. Broderick, MD & Seth Cohen, MD, MPH

05:00 p.m. - 05:23 p.m.
Cardiovascular Disease and ED – How to Council Patients and What are the Next Steps
Martin Miner, MD

05:23 p.m. - 05:45 p.m.
Incorporating Cardiovascular Wellness/Men’s Health Promotion in Urologic Practice
Culley C. Carson III, MD, FACS, FRCS(hon)


05:00 p.m. - 06:00 p.m.
Moderated Posters: Priapism/Reconstruction
Location: Margaux 1
Moderators: Gerald B. Brock, MD & Robert C. Dean, MD

05:00 p.m. - 05:05 p.m.
Validation of the Priapism Profile Impact Questionnaire (#038)
B. Morrison

05:05 p.m. - 05:10 p.m.
A Retrospective Evaluation of the Safety and Effectiveness of a Silicone Block Implant for Elective Cosmetic Surgery of the Penis (#039)
O. Mirgoli

05:10 p.m. - 05:15 p.m.
Surgical Management of Acquired Buried Penis: Experience from Two Institutions (#040)
A. Herati

05:15 p.m. - 05:20 p.m.
Use of Phenylephrine in the Treatment of Ischemic Priapism: 5 year Experience at a Single Institution (#041)
D.G. Ridyard

05:20 p.m. - 05:25 p.m.
Buccal Mucosal Grafting in Peyronie’s Disease. Still not the Best (#042)
A. Zahran

05:25 p.m. - 05:30 p.m.
Complications and Surgical Management of Vaseline Injection Into the Penis for Girth Enhancement – A Photo Documentary: Support for the SMSNA’s Position on Penile Lengthening and Girth Enhancement. (#043)
Y. Krakowsky

05:30 p.m. - 05:35 p.m.
The Effect of Treatment for Priapism on Erectile Dysfunction (#044)
H. Levey Bernie

05:35 p.m. - 05:40 p.m.
Surgical Interventions for Priapism: The role of Penile Prostheses (#045)
M.J. Pagano

05:40 p.m. - 05:45 p.m.
Percutaneous Revision of a Testicular Prosthesis (#046)
M. Mendez

05:45 p.m. - 05:50 p.m.
Recovery of Glans Sensation Following Combined Dorsal and Ventral Onlay with a Glans Splitting Technique for Strictures of the Fossa Navicularis (#047)
M. Mendez

05:50 p.m. - 05:55 p.m.
Fertility Preservation in the Male to Female Transgender Patient: Role of Testis Sperm Extraction (TESE) and Testis Histology in Patients undergoing Gender Reassignment Surgery (#048)
S. Honig


05:00 p.m. - 06:00 p.m.
Moderated Posters: Epidemiology
Location: Margaux 2
Moderators: Maurice Garcia, MD, MAS & Mindy E. Goldman, MD

05:00 p.m. - 05:05 p.m.
Epidemiology of Penile Fractures in the Emergency Setting (#049)
S. Liu

05:05 p.m. - 05:10 p.m.
Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Intervention in Low-Risk Patients? (#050)
Lawrence C. Jenkins, MD, MBA

05:10 p.m. - 05:15 p.m.
Impact of Anal Sex Role on the HIV Protective Effect of Circumcision in MSM (#051)
D. Milam

05:15 p.m. - 05:20 p.m.
Testicular Torsion: Epidemiological Risk Factors for Orchiectomy in Pediatric and Adult Patients (#052)
G. Horn

05:20 p.m. - 05:25 p.m.
Evaluation of Doppler Parameters in Patients without Organic Erectile Dysfunction (#053)
Gregory A. Broderick, MD

05:25 p.m. - 05:30 p.m.
Post Finasteride Syndrome: Guess Who-Demographics from FDA Database (#054)
A. Lwin

05:30 p.m. - 05:35 p.m.
National Trends in the Diagnosis and Management of Psychogenic Erectile Dysfunction (#055)
D.J. Lee

05:35 p.m. - 05:40 p.m.
National Sex Survey in South Korea (#056)
D.G. Moon

05:40 p.m. - 05:45 p.m.
Changes in Erectile Dysfunction Over Time by age: A Community-Based Population Study (#057)
M.J. Ziegelmann

05:45 p.m. - 05:50 p.m.
Safe Space: LGBTQ training at the University of Miami (#058)
S. Kenya